z-logo
open-access-imgOpen Access
Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4+ T cells
Author(s) -
Jianyou Gu,
Junfeng Zhang,
Wenjie Huang,
Tian Tao,
Yaohuan Huang,
Ludi Yang,
Jiali Yang,
Yingfang Fan,
Huaizhi Wang
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.03.53
Subject(s) - gemcitabine , microrna , pancreatic cancer , biology , immune system , cancer research , medicine , gene , oncology , cancer , immunology , genetics
Gemcitabine resistance can alter the fraction of memory CD4 T cells via hsa-miR-3178, hsa-miR-485-3p, hsa-miR-574-5p and hsa-miR-584-5p targeted MSI2, TEAD1, GNPDA1, RND3, PRKACB, TRIM68, and YKT6 network in PC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom